-
Privacy, Power & Empowerment: How Period Trackers Fail to Protect Women
Abigail PatchenPeriod-tracking applications occupy a large share of the FemTech industry, offering users intimate insights into their reproductive health while simultaneously exposing them to unprecedented privacy risks. Period-tracking apps regularly disseminate highly sensitive health data under the protection of the notice and consent paradigm of privacy law, an outdated framework that places the burden of privacy […]
Read More -
AI in Pharmaceutical Research and Development: A Tiered Proposal Realigning Regulatory Exclusivity Periods
Ingrid VillarrealThis Note examines how artificial intelligence (“AI”) is fundamentally transforming pharmaceutical research and development (“R&D”), altering the cost, risk, and timelines that traditionally justify regulatory exclusivity protections. As AI-enabled technologies accelerate drug discovery and increase clinical success rates, the traditional assumptions supporting lengthy exclusivity periods are becoming less persuasive. This Note contends that Congress should […]
Read More -
The Algorithmic Antitrust Paradox
Meher SethiWhen algorithms fix prices instead of CEOs, does antitrust law have an answer? Scholars have largely lamented the so-called liability gap, dismissing algorithmic tacit collusion as lacking an ‘agreement’ between competitors and thereby evading the watchful eye of the antitrust laws. This Article challenges that premise, developing a legal theory on which algorithmic tacit collusion […]
Read More